Sudeep Pharma
Ticker > Company >

Sudeep Pharma share price

Sudeep Pharma Ltd.

 14   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year3.77%
3 Year1.13%
5 Year23.73%

Profit Growth

1 Year-2.38%
3 Year22.33%
5 Year39.63%

ROE%

1 Year25.12%
3 Year30.87%
5 Year32.99%

ROCE %

1 Year28.72%
3 Year34.06%
5 Year35.27%

Debt/Equity

0.2746

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 30.8668666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 34.0622333333333% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Promoter stake has increased from 0% to 100% in the last 1 quarter.

 Limitations

  • The company has shown a poor revenue growth of 1.12608314163516% for the Past 3 years.
  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 217.89 344.95 404 343.76 356.73
Total Expenditure 172.11 276.8 315.73 210.83 223.9
Operating Profit 45.78 68.15 88.26 132.93 132.83
Other Income 3.67 8.08 11.18 8.2 8.38
Interest 0.97 1.63 3.84 3.68 5.68
Depreciation 3.53 4.19 4.83 5.15 6.12
Exceptional Items 0 0 0 0 0
Profit Before Tax 44.96 70.4 90.77 132.31 129.41
Tax 9.97 18.1 23.6 34.23 33.66
Net Profit 34.99 52.31 67.17 98.08 95.75
Adjusted EPS (Rs.) 3.6 5.39 6.92 10.1 9.85

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.41 1.41 1.41 1.41 11.98
Total Reserves 114.53 166.83 235.47 333.19 418.14
Borrowings 14.1 17.2 11 5.16 36.44
Other N/C liabilities 4.91 5.66 4.44 6.33 6.72
Current liabilities 78.88 142.07 163.71 104.51 130.82
Total Liabilities 213.81 333.17 416.03 450.6 604.1
Assets
Net Block 67.65 119.96 81.35 95.88 105.27
Capital WIP 23.21 4.38 25.59 43.5 87.71
Intangible WIP 0 0 0 0 0
Investments 24.21 15.11 15.67 28.62 31.37
Loans & Advances 2.46 1.89 8.08 11.09 26.66
Other N/C Assets 0 0 49.47 40.76 40.06
Current Assets 96.29 191.83 235.85 230.75 313.02
Total Assets 213.81 333.17 416.03 450.6 604.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 132.31 129.41
Adjustment 8.39 8.96
Changes in Assets & Liabilities -45.42 -49.54
Tax Paid -36.23 -29.68
Operating Cash Flow 59.05 59.15
Investing Cash Flow -40.67 -91.59
Financing Cash Flow -16.14 54.2
Net Cash Flow 2.24 21.75

Corporate Actions

Last Updated on:
Brief about Sudeep Pharma
X